Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
OnkoRisk Hereditary Oncology Plus Panel BioReference Health United States | 97 | 77 |
|
CNS Tumor Classification by Methylation Array Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital United States | 9 | 2 |
|
Centogene AG - the Rare Disease Company Germany | 156 | 107 |
|
KIF1B - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 325 | 316 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital United States | 1 | 8 |
|
Genome-Nilou Lab Iran | 45 | 34 |
|
MYCN (N-Myc) Amplification Detection for Neuroblastoma Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital United States | 1 | 1 |
|
Targeted Oncology Microarray Analysis Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital United States | 7 | 7 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 346 | 160 |
|
PreventionGenetics, part of Exact Sciences United States | 78 | 64 |
|
PrimBio Research Institute United States | 60 | 50 |
|
PreventionGenetics, part of Exact Sciences United States | 3 | 3 |
|
PreventionGenetics, part of Exact Sciences United States | 122 | 117 |
|
Baylor Genetics United States | 842 | 637 |
|
Hereditary Neuroblastoma via the KIF1B Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.